Comparison of p53, Ki-67, and CD44v6 expression between primary and matched metastatic lesions in ovarian cancer

Citation
K. Sakai et al., Comparison of p53, Ki-67, and CD44v6 expression between primary and matched metastatic lesions in ovarian cancer, GYNECOL ONC, 72(3), 1999, pp. 360-366
Citations number
32
Categorie Soggetti
Reproductive Medicine
Journal title
GYNECOLOGIC ONCOLOGY
ISSN journal
00908258 → ACNP
Volume
72
Issue
3
Year of publication
1999
Pages
360 - 366
Database
ISI
SICI code
0090-8258(199903)72:3<360:COPKAC>2.0.ZU;2-5
Abstract
Objective. Many studies have demonstrated that clinically evident tumor cel ls already carry multiple genetic alterations and further accumulation of g enetic alteration causes tumor progression which plays a role in metastasis . Therefore, it could be expected that malignant potential in the metastati c site is more aggressive than that in the primary site. Using several immu nohistochemical markers (p53, Ki-67, and CD44v6), we investigated an altera tion of malignant potential. Methods. We immunohistochemically examined expression of p53, Ki-67, and CD 44 in primary and metastatic lesions of ovarian cancer. Fifty-six samples o f primary lesions and matched metastatic sites from 56 patients with primar y epithelial ovarian cancers were included in this study. Results. In 16 cases (28%), the histological grade of the metastatic lesion increased. This difference was statistically significant (P = 0.0232). In 16 cases (28%), the expression of p53 increased in the metastatic lesions, in 5 pairs from negative to positive, whereas the case decrease in the meta static lesions was only 1. This difference was statistically significant (P = 0.0046). There was no significant difference in Ki-67 labeling indices a nd expression of CD44v6 between the primary and matched metastatic lesions. The degree of p53 expression in the metastatic lesions significantly corre lated with disease-free survival (P = 0.0482), whereas that in the primary lesions did not. Moreover, high p53 expression in the metastatic lesions si gnificantly correlated with disease-free survival in multivariate analysis. Conclusions. The p53 expression in metastatic lesions may reflect an aggres sive biologic behavior in ovarian cancer. (C) 1999 Academic Press.